1. Upregulated lncRNA CASC9 Contributes to Progression of Non-Small Cell Lung Cancer Through Inhibition of miR-335-3p and Activation S100A14 Expression


    Weigang Zhao et al, 2020, OncoTargets and Therapy CrossRef
  2. Trypanosoma cruzi Isolates Naturally Adapted to Congenital Transmission Display a Unique Strategy of Transplacental Passage
    Paula Faral-Tello et al, 2023, Microbiology Spectrum CrossRef
  3. Roles of S100 family members in drug resistance in tumors: Status and prospects
    Xin Hua et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  4. Calcium signals and potential therapy targets in ovarian cancer (Review)
    Fengying Deng et al, 2023, International Journal of Oncology CrossRef
  5. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer
    Hong-Yu Xu et al, 2020, Medicine CrossRef
  6. A machine learning approach to identify predictive molecular markers for cisplatin chemosensitivity following surgical resection in ovarian cancer
    Nicholas Brian Shannon et al, 2021, Scientific Reports CrossRef
  7. Pan‐cancer clinical and molecular analysis of racial disparities
    Olivia D. Lara et al, 2020, Cancer CrossRef
  8. CSGALNACT2 restricts ovarian cancer migration and invasion by modulating MAPK/ERK pathway through DUSP1
    Mingjun Ma et al, 2024, Cellular Oncology CrossRef
  9. Expression profile and functional role of S100A14 in human cancer
    Suyog Basnet et al, 2019, Oncotarget CrossRef
  10. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer
    Hongwei Zhu et al, 2021, Pancreatology CrossRef
  11. Identification of S100A14 as a metastasis-promoting molecule in a murine organotropic metastasis model
    Takashi Sugino et al, 2019, Clinical & Experimental Metastasis CrossRef
  12. Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas
    Olga Kelemen et al, 2020, Clinical and Translational Medicine CrossRef
  13. Congenital Transmission of Trypanosoma cruzi: A Review About the Interactions Between the Parasite, the Placenta, the Maternal and the Fetal/Neonatal Immune Responses
    Ulrike Kemmerling et al, 2019, Frontiers in Microbiology CrossRef
  14. Mediation of circ_0007142 on miR-128-3p/S100A14 pathway to stimulate the progression of cervical cancer
    Qinqin Feng et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
  15. S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte–NK Crosstalk
    Krystal Colón et al, 2019, JAIDS Journal of Acquired Immune Deficiency Syndromes CrossRef
  16. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin
    Lingzhi Wang et al, 2019, Journal of Ovarian Research CrossRef
  17. S100A14 serum level and its correlation with prognostic factors in breast cancer
    Noor Al-Ashkar et al, 2020, Journal of the Egyptian National Cancer Institute CrossRef
  18. A multiomics analysis of S100 protein family in breast cancer
    Patrizia Cancemi et al, 2018, Oncotarget CrossRef